Articles published by AOP Health

ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings

Today 13:48 EDT

From AOP Health

Via Business Wire

AOP Health on Rare Diseases: Information. Collaboration. Innovation.

February 23, 2026

From AOP Health

Via Business Wire

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

January 12, 2026

From AOP Health

Via GlobeNewswire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH

December 07, 2025

From AOP Health

Via Business Wire

ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)

February 17, 2025

From AOP Health

Via Business Wire

AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera

May 11, 2023

From AOP Health

Via Business Wire

AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera

June 01, 2023

From AOP Health

Via Business Wire

AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting

December 13, 2022

From AOP Health

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.